No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs8004619 |
chr14:66980652-66980653 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs536484475 |
chr14:66980670-66980671 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs182672308 |
chr14:66980743-66980744 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs367635758 |
chr14:66980799-66980800 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs576251574 |
chr14:66980896-66980897 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs545073941 |
chr14:66980954-66980955 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs113445957 |
chr14:66980981-66980982 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs571970644 |
chr14:66980983-66980984 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs540590068 |
chr14:66981033-66981034 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs112878896 |
chr14:66981043-66981044 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs560875817 |
chr14:66981066-66981067 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs116871228 |
chr14:66981069-66981070 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs529552312 |
chr14:66981190-66981191 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs35802045 |
chr14:66981203-66981204 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs117132215 |
chr14:66981212-66981213 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs562699401 |
chr14:66981227-66981228 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs531704515 |
chr14:66981239-66981240 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs551430126 |
chr14:66981302-66981303 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs571575466 |
chr14:66981337-66981338 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs188815063 |
chr14:66981361-66981362 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs547457215 |
chr14:66981400-66981401 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs567589147 |
chr14:66981425-66981426 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs531377755 |
chr14:66981435-66981436 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs193209680 |
chr14:66981548-66981549 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs561313879 |
chr14:66981634-66981635 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs556395824 |
chr14:66981640-66981641 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs199929257 |
chr14:66981740-66981741 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs548005033 |
chr14:66981794-66981795 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs148009556 |
chr14:66981800-66981801 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs538753316 |
chr14:66981827-66981828 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs546900492 |
chr14:66981860-66981861 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs558592215 |
chr14:66981864-66981865 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs572032277 |
chr14:66981920-66981921 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541062302 |
chr14:66981922-66981923 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs11622637 |
chr14:66981923-66981924 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs571876524 |
chr14:66981925-66981926 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs554265335 |
chr14:66981945-66981946 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs573997660 |
chr14:66981987-66981988 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs542874836 |
chr14:66981988-66981989 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs74245900 |
chr14:66982025-66982026 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs368663925 |
chr14:66982069-66982070 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs141663262 |
chr14:66982127-66982128 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs376832174 |
chr14:66982159-66982160 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs570625539 |
chr14:66982211-66982212 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs28548143 |
chr14:66982217-66982218 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
46 |
rs79194468 |
chr14:66982314-66982315 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs546679554 |
chr14:66982405-66982406 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs527772523 |
chr14:66982421-66982422 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs547815250 |
chr14:66982468-66982469 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs76416301 |
chr14:66982507-66982508 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|